These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18998996)

  • 1. Comparison of two drug-burden computational procedures applied to anticholinergic drugs.
    Slattum PW; Vargas-Irwin C; Dharia SP; Robles JR
    AMIA Annu Symp Proc; 2008 Nov; ():1138. PubMed ID: 18998996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs with anticholinergic properties: a current perspective on use and safety.
    Gerretsen P; Pollock BG
    Expert Opin Drug Saf; 2011 Sep; 10(5):751-65. PubMed ID: 21635190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to atropinic drugs and frailty status.
    Moulis F; Moulis G; Balardy L; Gérard S; Montastruc F; Sourdet S; Rougé-Bugat ME; Lapeyre-Mestre M; Montastruc JL; Rolland Y; Vellas B
    J Am Med Dir Assoc; 2015 Mar; 16(3):253-7. PubMed ID: 25548029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.
    Kalisch Ellett LM; Pratt NL; Ramsay EN; Barratt JD; Roughead EE
    J Am Geriatr Soc; 2014 Oct; 62(10):1916-22. PubMed ID: 25284144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Anticholinergic Medication Use in the Program of All-Inclusive Care for the Elderly.
    Covington LP; McCarrell J; Hoerster NS
    Consult Pharm; 2016 Mar; 31(3):168-74. PubMed ID: 26975596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.
    Salahudeen MS; Hilmer SN; Nishtala PS
    J Am Geriatr Soc; 2015 Jan; 63(1):85-90. PubMed ID: 25597560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The adverse effects of anticholinergic drugs].
    Iwaki H; Nomoto M
    Brain Nerve; 2014 May; 66(5):551-60. PubMed ID: 24807371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anticholinergic burden of medications in older adults.
    West T; Pruchnicki MC; Porter K; Emptage R
    J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people.
    Gnjidic D; Le Couteur DG; Abernethy DR; Hilmer SN
    Ann Pharmacother; 2010 Nov; 44(11):1725-32. PubMed ID: 20876826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial.
    Griebling TL
    J Urol; 2014 Apr; 191(4):1055. PubMed ID: 24703133
    [No Abstract]   [Full Text] [Related]  

  • 13. An optimal dynamic inversion-based neuro-adaptive approach for treatment of chronic myelogenous leukemia.
    Padhi R; Kothari M
    Comput Methods Programs Biomed; 2007 Sep; 87(3):208-24. PubMed ID: 17618012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological systems drug infusion controller using FREN with sliding bounds.
    Chidentree T; Sermsak U
    IEEE Trans Biomed Eng; 2006 Nov; 53(11):2405-8. PubMed ID: 17073348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculating and using the drug burden index score in research and practice.
    Hilmer SN
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1053-1055. PubMed ID: 30269609
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability.
    Ko JH; Kim WH; Chung CC
    IEEE Trans Biomed Eng; 2006 Mar; 53(3):380-6. PubMed ID: 16532764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticholinergic delirium--diagnosis and therapy].
    Sperling W; Mösler T
    Fortschr Med; 1995 Jan; 113(1-2):29-30, 33. PubMed ID: 7883263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
    Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
    Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample.
    Block CK; Logue E; Thaler NS; Scarisbrick DM; Mahoney JJ; Scott J; Duff K
    Arch Clin Neuropsychol; 2015 Mar; 30(2):105-13. PubMed ID: 25549761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert-based drug lists to measure anticholinergic burden: similar names, different results.
    Lertxundi U; Domingo-Echaburu S; Hernandez R; Peral J; Medrano J
    Psychogeriatrics; 2013 Mar; 13(1):17-24. PubMed ID: 23551407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.